Home » Stocks » Avanos Medical

Avanos Medical, Inc. (AVNS)

Stock Price: $31.75 USD 0.57 (1.83%)
Updated Aug 11, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 1.52B
Revenue (ttm) 705.30M
Net Income (ttm) -16.90M
Shares Out 47.83M
EPS (ttm) -0.35
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 11, 2020
Last Price $31.75
Previous Close $31.18
Change ($) 0.57
Change (%) 1.83%
Day's Open 31.76
Day's Range 31.32 - 32.17
Day's Volume 211,137
52-Week Range 19.46 - 48.07

More Stats

Market Cap 1.52B
Enterprise Value 1.66B
Earnings Date (est) Nov 10, 2020
Ex-Dividend Date n/a
Shares Outstanding 47.83M
Float 47.47M
EPS (basic) -0.34
EPS (diluted) -0.35
FCF / Share -1.08
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.60M
Short Ratio 8.76
Short % of Float 6.25%
Beta 1.18
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2.15
PB Ratio 1.17
Revenue 705.30M
Operating Income -7.80M
Net Income -16.90M
Free Cash Flow -51.50M
Net Cash -137.70M
Net Cash / Share -2.88
Gross Margin 57.03%
Operating Margin -1.11%
Profit Margin -2.40%
FCF Margin -7.30%
ROA -0.25%
ROE -1.33%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (8)

Buy 3
Overweight 0
Hold 4
Underweight 0
Sell 1

Analyst Consensus: Overweight

Price Target

$35.50*
(11.81% upside)
Low
30.0
Current: $31.75
High
43.0
Target: 35.50
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014201320122011
Revenue6986526125665091,6721,6781,6841,660
Revenue Growth6.94%6.65%8.02%11.24%-69.56%-0.32%-0.39%1.45%-
Gross Profit402391337297258549612603591
Operating Income-34.608.70-23.00-87.40-12090.50223227208
Net Income-45.9057.5079.3039.80-42627.10155153142
Shares Outstanding47.9347.4346.8446.6746.6146.5446.54--
Earnings Per Share-0.961.221.690.85-9.150.583.323.28-
EPS Growth--27.81%98.82%---82.53%1.22%--
Operating Cash Flow-74.50-14614418997.60148224203140
Capital Expenditures-50.60-49.10-43.10-25.90-62.60-70.70-48.70-40.30-35.80
Free Cash Flow-125-19510116335.0077.20175162104
Cash & Equivalents20538522011413014944.1047.900.00
Total Debt32524858157957862711.9075.90-
Net Cash / Debt-120137-361-465-449-47832.20-28.000.00
Assets1,8001,8332,1962,0722,0002,5182,4842,534-
Liabilities5345369819699451,027405479-
Book Value1,2651,2971,2151,1031,0551,4912,0792,056-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Avanos Medical, Inc.
Country United States
Employees 4,700
CEO Joseph F. Woody

Stock Information

Ticker Symbol AVNS
Stock Exchange New York Stock Exchange
Unique Identifier NYSE: AVNS

Description

Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Its product portfolio includes digestive health products, including enteral feeding tubes and solutions; respiratory health products, such as closed airway suction systems and oral care kits; and acute pain products comprising surgical pain pumps, and cold and compression therapy systems, as well as interventional pain management solutions that include minimally invasive interventional pain therapies. The company sells its products under the MIC-KEY, CORPAK, NEOMED, BALLARD, MICROCUFF, ENDOCLEAR, ON-Q, AMBIT, GAME READY, and COOLIEF brand names. It markets its products directly to hospitals and other healthcare providers, and through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.